Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Read more about Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis.
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status. Read more about Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study. Read more about Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126. Read more about Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry. Read more about Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors. Read more about Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis. Read more about Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Read more about Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy. Read more about A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers. Read more about Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
